Live Breaking News & Updates on Pituitary Society|Page 5

Stay updated with breaking news from Pituitary society. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Preop TT3 Predicts HPA Axis Recovery After Cushing Surgery

Recovery occurred within 2 years in nearly three quarters of patients in a retrospective review at a single Chinese medical center. ....

Cushings Syndrome , Thyroid Disorder , Adrenal Crisis , Adrenal Insufficiency , Diabetes Insipidus , Peer Review ,

Lack of Sleep Disrupts Body Clock, Hormones

Reverse schedules can disrupt the body s circadian rhythm, particularly in night-shift workers. Dr Peter Liu shares insight into new research on shift workers, hypogonadism, and hormones. ....

Los Angeles , Peter Liu , Washington State University , David Geffen School Of Medicine , Lundquist Institute , David Geffen School , Medical News , Sleep Deprivation , Testosterone Therapy , Metabolic Syndrome , Insulin Resistance , Sleep Disorder , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Adverse Effects , Side Effects ,

What if This Wasn't Menopause After All? - The New York Times

The patient had the full suite of symptoms and a jaw that somehow moved out of alignment. That was the clue something was wrong. ....

Lisa Sanders , Robert Souferian , Joan Cantero , Bay Ridge , Closer Look , Most Baffling Medical Mysteries ,

Copeptin Rules Out Diabetes Insipidus Post Pituitary Surgery

A review of 78 transsphenoidal adenomectomy patients at a UK center found that a high copeptin level 1 day after surgery reliably ruled out incident diabetes insipidus and allowed early discharge. ....

United Kingdom , Research Square , John Radcliffe Hospital , Diabetes Insipidus , Antidiuretic Hormone , Dh Antidiuretic Hormone , Pituitary Tumor , Umor Of The Pituitary , Inpatient Care , Peer Review ,

Oral octreotide as good as injectable somatostatin receptor ligands for acromegaly treatment: Lancet

Moscow, Russia: New research found that oral octreotide was not inferior to injectable somatostatin receptor ligands (iSRLs) medication and may be a better option for many people with acromegaly. This. ....

Moskovskaya Oblast , Pskovskaya Oblast , United States , Maria Fleseriu , Lancet Diabetes , Oral Drug , Growth Hormone , Omatostatin Receptors , Hormone Injection , Prof Maria Fleseriu ,